A new trading day began on Friday, with Dare Bioscience Inc (NASDAQ: DARE) stock price up 18.18% from the previous day of trading, before settling in for the closing price of $2.09. DARE’s price has ranged from $1.61 to $9.19 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 47.17%. Meanwhile, its annual earnings per share averaged -247.53%. With a float of $12.78 million, this company’s outstanding shares have now reached $13.93 million.
Dare Bioscience Inc (DARE) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Dare Bioscience Inc is 11.21%, while institutional ownership is 7.06%.
Dare Bioscience Inc (DARE) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.65 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -247.53% per share during the next fiscal year.
Dare Bioscience Inc (NASDAQ: DARE) Trading Performance Indicators
Here are Dare Bioscience Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.44, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of Dare Bioscience Inc (DARE)
Looking closely at Dare Bioscience Inc (NASDAQ: DARE), its last 5-days average volume was 0.67 million, which is a jump from its year-to-date volume of 0.47 million. As of the previous 9 days, the stock’s Stochastic %D was 82.06%.
During the past 100 days, Dare Bioscience Inc’s (DARE) raw stochastic average was set at 72.27%, which indicates a significant decrease from 94.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.13 in the past 14 days, which was higher than the 0.11 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.95, while its 200-day Moving Average is $2.46. However, in the short run, Dare Bioscience Inc’s stock first resistance to watch stands at $2.61. Second resistance stands at $2.74. The third major resistance level sits at $2.96. If the price goes on to break the first support level at $2.25, it is likely to go to the next support level at $2.03. Should the price break the second support level, the third support level stands at $1.89.
Dare Bioscience Inc (NASDAQ: DARE) Key Stats
With a market capitalization of 35.29 million, the company has a total of 14,289K Shares Outstanding. Currently, annual sales are 10 K while annual income is -4,050 K. The company’s previous quarter sales were -20 K while its latest quarter income was -4,020 K.
